Florence A. Aeschlimann

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease

Florence A. Aeschlimann, Ezgi Deniz Batu, Scott Canna et al. · Annals of the Rheumatic Diseases · 2018 · 217 citations

JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study

Tom Le Voyer, Cyril Gitiaux, François‐Jérôme Authier et al. · Lara D. Veeken · 2021 · 77 citations

Childhood Takayasu arteritis: disease course and response to therapy

Florence A. Aeschlimann, Simon Eng, Shehla Sheikh et al. · Arthritis Research & Therapy · 2017 · 75 citations · Full text

Presentation and Disease Course of Childhood‐Onset Versus Adult‐Onset Takayasu Arteritis

Florence A. Aeschlimann, Lillian Barra, Roaa Alsolaimani et al. · Arthritis & Rheumatology · 2018 · 57 citations